Exhibit 10.25
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position |
Fiscal 2007 Base Salary ($) |
Fiscal 2008 Base Salary ($) |
Fiscal 2007 Bonus ($) | |||
| Peter D. Meldrum President and Chief Executive Officer |
676,500 | 727,000 | 550,000 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. |
465,000 | 500,000 | 350,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. |
465,000 | 500,000 | 300,000 | |||
| Jay M. Moyes Chief Financial Officer |
355,000 | 380,000 | 220,000 | |||
| Mark H. Skolnick, Ph.D. (1) Chief Scientific Officer |
480,600 | 500,000 | 150,000 |
| (1) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |